UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 816

Sortiert nach

Minireview: Challenges and Opportunities in Development of PPAR Agonists

Molecular endocrinology (Baltimore, Md.), 2014-11, Vol.28 (11), p.1756-1768

2014

Link zum Volltext

Verfügbarkeit prüfen

Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress

PloS one, 2017-11, Vol.12 (11), p.e0188596

2017

Link zum Volltext

Verfügbarkeit prüfen

Insulin Receptor and Glucose Transporters in the Mammalian Cochlea

Audiology & neurotology, 2019-01, Vol.24 (2), p.65-76

2019

Link zum Volltext

Verfügbarkeit prüfen

Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease

Nature communications, 2021-08, Vol.12 (1), p.4662-4662, Article 4662

2021

Link zum Volltext

Verfügbarkeit prüfen

Pioglitazone Ameliorates Gentamicin Ototoxicity by Affecting the TLR and STAT Pathways in the Early Postnatal Organ of Corti

Frontiers in cellular neuroscience, 2020-10, Vol.14, p.566148-566148

2020

Link zum Volltext

Verfügbarkeit prüfen

Examining the safety of PPAR agonists - current trends and future prospects

Expert opinion on drug safety, 2013-01, Vol.12 (1), p.65-79

2013

Link zum Volltext

Verfügbarkeit prüfen

6‑Alkoxy-5-aryl-3-pyridinecarboxamides, a New Series of Bioavailable Cannabinoid Receptor Type 1 (CB1) Antagonists Including Peripherally Selective Compounds

Journal of medicinal chemistry, 2013-12, Vol.56 (24), p.9874-9896

2013

Link zum Volltext

Verfügbarkeit prüfen

Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage

Biochemical journal, 2011-09, Vol.438 (2), p.315-323

2011

Link zum Volltext

Verfügbarkeit prüfen

The Ras Inhibitors Caveolin-1 and Docking Protein 1 Activate Peroxisome Proliferator-Activated Receptor γ through Spatial Relocalization at Helix 7 of Its Ligand-Binding Domain

Molecular and Cellular Biology, 2011-08, Vol.31 (16), p.3497-3510

2011

Link zum Volltext

Verfügbarkeit prüfen

Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats

Journal of bone and mineral metabolism, 2015-11, Vol.33 (6), p.625-641

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes

PloS one, 2012-04, Vol.7 (4), p.e35012-e35012

2012

Link zum Volltext

Verfügbarkeit prüfen

Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice

Journal of molecular medicine (Berlin, Germany), 2019-08, Vol.97 (8), p.1127-1138

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of SSH PCR in isolating differentially expressed genes

BMC genomics, 2002-05, Vol.3 (1), p.12-12, Article 12

2002

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid–induced liver hypertrophy

Hepatology (Baltimore, Md.), 2009-03, Vol.49 (3), p.979-988

2009

Link zum Volltext

Verfügbarkeit prüfen

Pasireotide prevents nuclear factor of activated T cells nuclear translocation and acts as a protective agent in aminoglycoside‐induced auditory hair cell loss

Journal of neurochemistry, 2016-12, Vol.139 (6), p.1113-1123

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparative Molecular Profiling of the PPARα/γ Activator Aleglitazar: PPAR Selectivity, Activity and Interaction with Cofactors

ChemMedChem, 2012-06, Vol.7 (6), p.1101-1111

2012

Link zum Volltext

Verfügbarkeit prüfen

A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors

The Journal of biological chemistry, 2006-02, Vol.281 (8), p.4920

2006

Link zum Volltext

Verfügbarkeit prüfen

New Insights on the Mechanism of PPAR-targeted Drugs

ChemMedChem, 2010-12, Vol.5 (12), p.1973-1976

2010

Link zum Volltext

Verfügbarkeit prüfen

Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin

Current drug metabolism, 2006-02, Vol.7 (2), p.119

2006

Link zum Volltext

Verfügbarkeit prüfen

MARCO, a macrophage scavenger receptor highly expressed in rodents, mediates dalcetrapib-induced uptake of lipids by rat and mouse macrophages

Toxicology in vitro, 2010-04, Vol.24 (3), p.745-750

2010

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and evaluation of anilinohexafluoroisopropanols as activators/modulators of LXRα and β

Bioorganic & medicinal chemistry letters, 2006-10, Vol.16 (19), p.5231-5237

2006

Link zum Volltext

Verfügbarkeit prüfen

Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences

The Journal of pharmacology and experimental therapeutics, 2001-01, Vol.296 (1), p.113

2001

Link zum Volltext

Verfügbarkeit prüfen

Protein-tyrosine phosphatases in the vessel wall: differential expression after acute arterial injury

Arteriosclerosis, thrombosis, and vascular biology, 2000-05, Vol.20 (5), p.1189

2000

Link zum Volltext

Verfügbarkeit prüfen

A Novel Principle for Partial Agonism of Liver X Receptor Ligands

The Journal of biological chemistry, 2006-02, Vol.281 (8), p.4920-4930

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 816

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(759)
Mit Volltextzugriff
(729)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(580)
Life Sciences & Biomedicine
(459)
Humans
(375)
Female
(219)
Male
(209)
Middle Aged
(134)
Adult
(119)
Animals
(100)
Aged
(99)
Biological And Medical Sciences
(98)
Medical Sciences
(81)
Physical Sciences
(77)
Risk Factors
(73)
Adolescent
(49)
General & Internal Medicine
(49)
Surgery
(48)
Child
(47)
Science & Technology - Other Topics
(46)
Neurosciences & Neurology
(45)
Medicine, General & Internal
(44)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Minireview: Challenges and Opportunities in Development of PPAR Agonists

Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress

Insulin Receptor and Glucose Transporters in the Mammalian Cochlea

Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease

Pioglitazone Ameliorates Gentamicin Ototoxicity by Affecting the TLR and STAT Pathways in the Early Postnatal Organ of Corti

Examining the safety of PPAR agonists - current trends and future prospects

6‑Alkoxy-5-aryl-3-pyridinecarboxamides, a New Series of Bioavailable Cannabinoid Receptor Type 1 (CB1) Antagonists Including Peripherally Selective Compounds

Farnesoid X receptor protects human and murine gastric epithelial cells against inflammation-induced damage

The Ras Inhibitors Caveolin-1 and Docking Protein 1 Activate Peroxisome Proliferator-Activated Receptor γ through Spatial Relocalization at Helix 7 of Its Ligand-Binding Domain

Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats

Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes

Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice

Efficacy of SSH PCR in isolating differentially expressed genes

Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid–induced liver hypertrophy

Pasireotide prevents nuclear factor of activated T cells nuclear translocation and acts as a protective agent in aminoglycoside‐induced auditory hair cell loss

Comparative Molecular Profiling of the PPARα/γ Activator Aleglitazar: PPAR Selectivity, Activity and Interaction with Cofactors

A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors

New Insights on the Mechanism of PPAR-targeted Drugs

Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin

MARCO, a macrophage scavenger receptor highly expressed in rodents, mediates dalcetrapib-induced uptake of lipids by rat and mouse macrophages

Discovery of Novel and Potent Leukotriene B4 Receptor Antagonists. Part 1

Synthesis and evaluation of anilinohexafluoroisopropanols as activators/modulators of LXRα and β

Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences

Protein-tyrosine phosphatases in the vessel wall: differential expression after acute arterial injury

A Novel Principle for Partial Agonism of Liver X Receptor Ligands

Suchergebnisse filtern